Page 4 of 32 · 745 questions tagged clinical-trials.
Setup, so nobody has to ask: 7.5 mg · mazdutide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my…
Conditions: 5 mg · tirzepatide. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the plan to…
Setup, so nobody has to ask: STEP 4 · a GLP-1 receptor agonist. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary…
Conditions: survodutide · 37 °C. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Has anyone…
Conditions: semaglutide · retatrutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I can…
Setup, so nobody has to ask: PIONEER-4 · dizziness · 25 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
The particulars: SURMOUNT-4 · constipation · 5 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is…
Setup, so nobody has to ask: STEP 3 · a GLP-1 receptor agonist. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary…
Conditions: SURPASS-2 · 10 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
Setup, so nobody has to ask: ESSENCE · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the…
My background is chemistry rather than physiology, which may explain where I am stuck. These are treated as interchangeable and I do not think they are. If both are…
Details up front: retatrutide · tirzepatide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
Details up front: a GLP-1 receptor agonist · SURMOUNT-4. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like…
What I have: a GLP-1 receptor agonist · 2–8 °C. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I…
Setup, so nobody has to ask: SUSTAIN-6 · vomiting. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
The US labelling for several drugs in this class carries a boxed warning about thyroid C-cell tumours, and it is stated fairly starkly — tumours in both rats and…
What I have: 0.5 mg · dulaglutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
I have reached a weight I am happy with on tirzepatide 12.5 mg and I do not want to keep losing. Cost is a factor and so is the fact that I would rather take less of…
What I am working with: orforglipron · mazdutide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain…
1.6 g/kg is quoted as though it were a physical constant. I would like to know what study it came from, what population, and whether the conditions of that study…
My eGFR is 92 and has been for years, which I had taken to mean my kidneys were not a topic. A urine albumin:creatinine ratio was added to a recent panel and came…
What I am working with: orforglipron · 40 °C. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all citing…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. Please show the division. I want to check my own against yours. I…
What I have: SURPASS-3 · tirzepatide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…